Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4181 studies found for:    Open Studies | "Immune System Diseases"
Show Display Options
Rank Status Study
21 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
22 Recruiting Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Condition: Graft vs Host Disease
Interventions: Biological: Begelomab;   Biological: Conventional Second-line Treatment
23 Recruiting Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: Entospletinib;   Drug: Placebo;   Drug: Systemic Corticosteroids
24 Recruiting Women Empowered to Live With Lupus Study
Condition: Lupus Erythematosus, Systemic
Intervention: Behavioral: Chronic Disease Self-Management Program (CDSMP)
25 Recruiting A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: KD025
26 Recruiting Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diseases;   Endocrine System Diseases;   Glucose Metabolism Disorders;   Immune System Diseases;   Metabolic Diseases
Intervention: Biological: Stem Cell Transplantation
27 Recruiting Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Conditions: Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Biological: ATLCAR.CD30 cells
28 Recruiting Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
Conditions: Hodgkin Disease;   Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Drug: ATLCAR.CD30 cells
29 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC);   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
Intervention:
30 Recruiting A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Conditions: Eczema;   Dermatitis;   Dermatitis, Atopic;   Genetic Disease, Inborn;   Hypersensitivity;   Hypersensitivity, Immediate;   Immune System Diseases;   Skin Diseases;   Skin Diseases, Eczematous;   Skin Diseases, Genetic
Interventions: Other: Care provided by general pediatrician;   Other: Care provided by pediatric dermatologist
31 Not yet recruiting Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin
Condition: Advanced Malignant Neoplasm
Interventions: Dietary Supplement: Fat Emulsion;   Other: Placebo
32 Not yet recruiting Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects
Condition: Primary Immunodeficiency Diseases (PID)
Interventions: Biological: HYQVIA;   Biological: KIOVIG;   Biological: Cuvitru
33 Not yet recruiting Validation of the French Version of the Pain Sensitivity Questionnaire
Conditions: Scheduled Surgery;   Healthy Volunteers
Intervention: Behavioral: Psychophysical exploration
34 Not yet recruiting A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Condition: Graft-versus-host Disease
Interventions: Drug: Ruxolitinib;   Drug: Extracorporeal photopheresis (ECP);   Drug: Low-dose methotrexate (MTX);   Drug: Mycophenolate mofetil (MMF);   Drug: mechanistic Target of Rapamycin (mTOR) inhibitors (everolimus or sirolimus);   Drug: Infliximab;   Drug: Rituximab;   Drug: Pentostatin;   Drug: Imatinib
35 Not yet recruiting Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease;   Hematopoietic Cell Transplantation Recipient
Interventions: Other: Dietary Intervention;   Other: Laboratory Biomarker Analysis
36 Recruiting Precision Allergy: Separate Allergies to Male and Female Dogs
Condition: Allergy; Dander
Interventions: Diagnostic Test: Male dog;   Diagnostic Test: Female dog
37 Recruiting Topical Vitamin D in Acute Graft Versus Host Disease of the Skin
Condition: Graft Vs Host Disease
Intervention: Dietary Supplement: Calcipotriene
38 Not yet recruiting Methodological Study to Compare the Effect of Different Methods of Measuring Cat Allergy Symptoms in Patients That Have Immunized Their Cats With FEL-CMV.
Condition: Hypersensitivity
Interventions: Other: Home-based test;   Other: Skin test
39 Recruiting Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)
Condition: Refractory Chronic Graft Versus Host Disease (cGVHD)
Intervention: Device: Photopheresis Theraflex ECP™
40 Recruiting Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies
Conditions: Myeloid Hematologic Malignancy;   Lymphoid Hematologic Malignancy
Intervention: Drug: Ixazomib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.